Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability.
Pati ML, Vitale P, Ferorelli S, Iaselli M, Miciaccia M, Boccarelli A, Di Mauro GD, Fortuna CG, Souza Domingos TF, Rodrigues Pereira da Silva LC, de Pádula M, Cabral LM, Sathler PC, Vacca A, Scilimati A, Perrone MG. Pati ML, et al. Among authors: cabral lm. Eur J Med Chem. 2019 Feb 15;164:59-76. doi: 10.1016/j.ejmech.2018.12.029. Epub 2018 Dec 15. Eur J Med Chem. 2019. PMID: 30590258
Sulphonamide and sulphonyl-hydrazone cyclic imide derivatives: antinociceptive activity, molecular modeling and in silico ADMET screening.
de Oliveira KN, Souza MM, Sathler PC, Magalhães UO, Rodrigues CR, Castro HC, Palm PR, Sarda M, Perotto PE, Cezar S, de Brito MA, Ferreira AS, Cabral LM, Machado C, Nunes RJ. de Oliveira KN, et al. Among authors: cabral lm. Arch Pharm Res. 2012 Oct;35(10):1713-22. doi: 10.1007/s12272-012-1002-1. Epub 2012 Nov 9. Arch Pharm Res. 2012. PMID: 23139121
Exploring N-acylhydrazone derivatives against clinical resistant bacterial strains.
Lannes AC, Leal B, Novais JS, Lione V, Monteiro GC, Lourenço AL, Sathler PC, Jordão AK, Rodrigues CR, Cabral LM, Cunha AC, Campos V, Ferreira VF, de Souza MC, Santos DO, Castro HC. Lannes AC, et al. Among authors: cabral lm. Curr Microbiol. 2014 Sep;69(3):357-64. doi: 10.1007/s00284-014-0591-y. Epub 2014 May 8. Curr Microbiol. 2014. PMID: 24807624
In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems: determination of novel NAH derivatives antiplatelet and nanotechnological approach.
Sathler PC, Lourenço AL, Rodrigues CR, da Silva LC, Cabral LM, Jordão AK, Cunha AC, Vieira MC, Ferreira VF, Carvalho-Pinto CE, Kang HC, Castro HC. Sathler PC, et al. Among authors: cabral lm. Thromb Res. 2014 Aug;134(2):376-83. doi: 10.1016/j.thromres.2014.05.009. Epub 2014 May 14. Thromb Res. 2014. PMID: 24877647
Titanium dioxide-montmorillonite nanocomposite as photoprotective agent against ultraviolet B radiation-induced mutagenesis in Saccharomyces cerevisiae: a potential candidate for safer sunscreens.
Paiva JP, Santos BA, Kibwila DM, Gonçalves TC, Pinto AV, Rodrigues CR, Leitão AC, Cabral LM, De Pádula M. Paiva JP, et al. Among authors: cabral lm. J Pharm Sci. 2014 Aug;103(8):2539-45. doi: 10.1002/jps.24057. Epub 2014 Jun 17. J Pharm Sci. 2014. PMID: 24942660
Therapeutic nanosystems for oral administration of insulin.
do Carmo FA, Sathler PC, Zancan P, Rodrigues CR, Castro HC, de Sousa VP, Sola-Penna M, Cabral LM. do Carmo FA, et al. Among authors: cabral lm. Curr Pharm Biotechnol. 2014;15(7):620-8. doi: 10.2174/1389201015666140915150826. Curr Pharm Biotechnol. 2014. PMID: 25219867 Review.
Platelets: still a therapeutical target for haemostatic disorders.
Geraldo RB, Sathler PC, Lourenço AL, Saito MS, Cabral LM, Rampelotto PH, Castro HC. Geraldo RB, et al. Among authors: cabral lm. Int J Mol Sci. 2014 Oct 7;15(10):17901-19. doi: 10.3390/ijms151017901. Int J Mol Sci. 2014. PMID: 25295482 Free PMC article. Review.
206 results